GO
General Oncology, Inc.
SEC filingPharmaceuticals · Newton, MA
Amount raised$4.8Msold at filing
Total offering$4.8M
Investors in the raise37count reported to the SEC
FiledApr 23, 2026first sale Apr 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Barry J. SeemanDirector
Arnold Aaron GlazierExecutive Officer, Director
Michael J. PetitDirector
Jeffrey Aaron GlazierExecutive Officer, Director
Abid Aaron AnsariExecutive Officer
Executive officers, directors and promoters as listed on the Form D.